Lester Lee

Array ( [id] => 1534960 [patent_doc_number] => 06489324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-03 [patent_title] => 'Piperazine compounds as inhibitors of MMP or TNF' [patent_app_type] => B2 [patent_app_number] => 09/982869 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58672 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 616 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489324.pdf [firstpage_image] =>[orig_patent_app_number] => 09982869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575233 [patent_doc_number] => 06469014 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Thieno2,3-d pyrimidinediones, their preparation and use in therapy' [patent_app_type] => B1 [patent_app_number] => 09/977944 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26242 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 664 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469014.pdf [firstpage_image] =>[orig_patent_app_number] => 09977944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420528 [patent_doc_number] => 06506758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-14 [patent_title] => 'Indole derivatives useful A.O. for the treatment of osteoporosis' [patent_app_type] => B2 [patent_app_number] => 09/975347 [patent_app_country] => US [patent_app_date] => 2001-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9919 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506758.pdf [firstpage_image] =>[orig_patent_app_number] => 09975347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291629 [patent_doc_number] => 06630473 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/890354 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6015 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630473.pdf [firstpage_image] =>[orig_patent_app_number] => 09890354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612739 [patent_doc_number] => 06903096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-07 [patent_title] => 'Quinazoline derivatives as medicaments' [patent_app_type] => utility [patent_app_number] => 09/972582 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 9326 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903096.pdf [firstpage_image] =>[orig_patent_app_number] => 09972582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093177 [patent_doc_number] => 06825199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => '7-Substituted quinazolin-2,4-diones useful as antibacterial agents' [patent_app_type] => B2 [patent_app_number] => 09/971343 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32232 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825199.pdf [firstpage_image] =>[orig_patent_app_number] => 09971343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017232 [patent_doc_number] => 20020103243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Sulfamoyl compounds and agricultural and horticultural fungicides' [patent_app_type] => new [patent_app_number] => 09/964357 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21222 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103243.pdf [firstpage_image] =>[orig_patent_app_number] => 09964357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017136 [patent_doc_number] => 20020103227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => '6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors' [patent_app_type] => new [patent_app_number] => 09/965564 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24627 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103227.pdf [firstpage_image] =>[orig_patent_app_number] => 09965564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1224202 [patent_doc_number] => 06699887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Anti-HIV pyrazole derivatives' [patent_app_type] => B2 [patent_app_number] => 09/956656 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24262 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 321 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699887.pdf [firstpage_image] =>[orig_patent_app_number] => 09956656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1156997 [patent_doc_number] => 06762186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists' [patent_app_type] => B2 [patent_app_number] => 09/955383 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11165 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/762/06762186.pdf [firstpage_image] =>[orig_patent_app_number] => 09955383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420501 [patent_doc_number] => 06506756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-14 [patent_title] => 'Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists' [patent_app_type] => B2 [patent_app_number] => 09/954867 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14839 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506756.pdf [firstpage_image] =>[orig_patent_app_number] => 09954867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601069 [patent_doc_number] => 06476033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Medicaments containing doxazosin mesylate of crystalline modification D' [patent_app_type] => B1 [patent_app_number] => 09/936792 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1727 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476033.pdf [firstpage_image] =>[orig_patent_app_number] => 09936792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6279621 [patent_doc_number] => 20020107392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Quinolinone derivatives' [patent_app_type] => new [patent_app_number] => 09/951265 [patent_app_country] => US [patent_app_date] => 2001-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50093 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107392.pdf [firstpage_image] =>[orig_patent_app_number] => 09951265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392752 [patent_doc_number] => 06544988 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/914985 [patent_app_country] => US [patent_app_date] => 2001-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10704 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 334 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544988.pdf [firstpage_image] =>[orig_patent_app_number] => 09914985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1285856 [patent_doc_number] => 06638927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-28 [patent_title] => 'Guanidinobenzamides' [patent_app_type] => B2 [patent_app_number] => 09/945384 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 34817 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638927.pdf [firstpage_image] =>[orig_patent_app_number] => 09945384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467314 [patent_doc_number] => 06458800 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => '1,2-annelated quinoline derivatives' [patent_app_type] => B1 [patent_app_number] => 09/868992 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12665 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 957 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458800.pdf [firstpage_image] =>[orig_patent_app_number] => 09868992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150671 [patent_doc_number] => 06770666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Fused-ring compounds and use thereof as drugs' [patent_app_type] => B2 [patent_app_number] => 09/939374 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95830 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770666.pdf [firstpage_image] =>[orig_patent_app_number] => 09939374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1180431 [patent_doc_number] => 06740651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-25 [patent_title] => 'Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases' [patent_app_type] => B2 [patent_app_number] => 09/934631 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8237 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740651.pdf [firstpage_image] =>[orig_patent_app_number] => 09934631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716475 [patent_doc_number] => 20030027823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'N,N\'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors' [patent_app_type] => new [patent_app_number] => 09/933598 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11646 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027823.pdf [firstpage_image] =>[orig_patent_app_number] => 09933598 [rel_patent_id] =>[rel_patent_doc_number] =>)